AimVion A/S: Financial statements 2018
CVR: 37120618
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
AimVion A/S (CVR 37120618) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -924,454 and a net result of DKK -1,536,957 compared with DKK -1,374,108 the year before. Equity in the 2018 report amounted to DKK 1,099,589. The solvency ratio was 94.1%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -924,454
- Profit/Loss
- DKK -1,536,957
- Equity
- DKK 1,099,589
- Total Assets
- DKK 1,168,461
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | -924 t. | -1.5 mio. | 1.1 mio. | 1 |
| 2017 | - | -1.1 mio. | -1.4 mio. | 2.1 mio. | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
AimVion A/S has published its annual report for 2017. Gross profit came to DKK -1,081,125, and the net result was DKK -1,374,108.
About AimVion A/S
AimVion A/S was a Danish company of the type Aktieselskab based in Aarhus C, founded in 2015. The company has been dissolved on 28 June 2023. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company was previously named StemGuard A/S and StemGuard ApS. The company has 1 employee (2020). In 2021, the company reported a gross profit of DKK -2,119,220 and a net result of DKK -1,734,826 compared with DKK -2,143,862 the year before. Equity in the 2021 report amounted to DKK 962,455.